CMS certification 220163
Umass Memorial Medical Center/University Campus
55 Lake Avenue North, Worcester, MA 01655
Umass Memorial Medical Center/University Campus has a CMS overall rating of 3 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. Emergency patients spend a median of 4 h 51 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,116 completed surveys, 22% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 366 visits sampled · US median for EDs of the same volume: 3 h 21 min | 4 h 51 min | 3 h 34 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 29 visits sampled | 14 h 4 min | 5 h 38 min | 4 h 17 min |
| Left before being seen Lower is better · 138,365 patients | 8% | 4% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 13 patients | 38% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 158 patients | 58% | 56% | 65% |
How Umass Memorial Medical Center/University Campus compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Umass Memorial Medical Center/University CampusThis hospital | 3/5 | 72% | 4 h 51 min | 5 better 2 worse |
| St Vincent HospitalSame city | 2/5 | 52% | 3 h 26 min | 4 better |
| Milford Regional Medical CenterSame county · Milford | 4/5 | 77% | 4 h 34 min | 1 better 4 worse |
| Umass Memorial Health - Harrington HospitalSame county · Southbridge | 3/5 | 65% | 3 h 29 min | 1 better 2 worse |
| Umass Memorial Healthalliance HospitalsSame county · Leominster | 3/5 | 54% | 4 h 13 min | 1 better 2 worse |
| Heywood HospitalSame county · Gardner | 2/5 | 71% | 3 h 12 min | 3 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Worcester.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 7,601 cases | Too few cases | 3.3% | 3.9% |
| Heart attack 523 cases | Too few cases | 11% | 11.9% |
| Heart failure 949 cases | Too few cases | 10.3% | 11.1% |
| Pneumonia 1,224 cases | Too few cases | 11.9% | 15.2% |
| Stroke 723 cases | Too few cases | 12.6% | 11.9% |
| COPD 370 cases | Too few cases | 7.8% | 8.6% |
| Heart bypass surgery (CABG) 148 cases | Too few cases | 2.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.97 likely 0.78 – 1.17 | 1 |
| After hip or knee replacement 215 cases | Too few cases | 3.6% | 4.1% |
| Deaths after a serious but treatable surgical complication 291 cases | Worse | 206.52 per 1,000 likely 174.43 per 1,000 – 238.62 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 16,751 cases | No different | 0.74 per 1,000 likely 0.38 per 1,000 – 1.1 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 18,090 cases | No different | 0.32 per 1,000 likely 0.16 per 1,000 – 0.48 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 18,797 cases | No different | 0.31 per 1,000 likely 0.15 per 1,000 – 0.47 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 4,624 cases | Worse | 3.61 per 1,000 likely 2.57 per 1,000 – 4.65 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,986 cases | No different | 1.43 per 1,000 likely 0.27 per 1,000 – 2.59 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,900 cases | No different | 6.95 per 1,000 likely 3.1 per 1,000 – 10.8 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,865 cases | No different | 4.11 per 1,000 likely 2.7 per 1,000 – 5.52 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,941 cases | No different | 4.11 per 1,000 likely 1.56 per 1,000 – 6.65 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,084 cases | No different | 1.48 per 1,000 likely 0.2 per 1,000 – 2.77 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,595 cases | No different | 0.74 per 1,000 likely 0.01 per 1,000 – 1.47 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.47 likely 0.31 – 0.69 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.42 likely 0.28 – 0.61 | 1 |
| Surgical site infections after colon surgery | No different | 0.84 likely 0.44 – 1.46 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 2.23 likely 0.9 – 4.63 | 1 |
| MRSA bloodstream infections | No different | 0.91 likely 0.57 – 1.38 | 1 |
| C. diff intestinal infections | Better | 0.35 likely 0.27 – 0.45 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 697 cases | Too few cases | 14.5% | 14.4% |
| Readmitted after heart failure 1,323 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 1,559 cases | Too few cases | 16.6% | 17.3% |
| Readmitted after COPD 599 cases | Too few cases | 20.3% | 20% |
| Readmitted after heart bypass surgery 163 cases | Too few cases | 11.4% | 11% |
| Readmitted after hip or knee replacement 204 cases | Too few cases | 6.2% | 5.8% |
| Days back in hospital after a heart attack 563 cases | Too few cases | 4 days per 100 | — |
| Days back in hospital after heart failure 1,074 cases | Too few cases | 0.2 days per 100 | — |
| Days back in hospital after pneumonia 1,239 cases | Too few cases | 24.7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 3,944 cases | No different | 13.8 per 1,000 likely 11.3 per 1,000 – 17 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 631 cases | Worse | 13.1 per 100 likely 10.9 per 100 – 15.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 631 cases | No different | 5 per 100 likely 3.8 per 100 – 6.5 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,458 cases | No different | 1 likely 0.8 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
2,436 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 599 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Practitioner | 305 |
| Physician Assistant | 200 |
| Emergency Medicine | 182 |
| Diagnostic Radiology | 132 |
| Anesthesiology | 115 |
| Internal Medicine | 115 |
| Nurse Anesthetist, Certified Registered | 98 |
| Clinical | 94 |
| Pediatrics | 74 |
| Neurology | 70 |
| Acute Care | 63 |
| Psychiatry | 52 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $3.7M
- 2020 $694,548
- 2021 $303,160
- 2022 $1M
- 2023 $1.7M
- 2024 $627,658
- 2025 $651,795
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Royalties and licensing fees | $151,422 | 3 |
| Speaking, teaching and other services | $123,550 | 109 |
| Medical devices and supplies on long-term loan | $110,735 | 27 |
| Grants | $100,000 | 1 |
| Space rental and facility fees | $36,772 | 1 |
| Debt forgiveness | $1,000 | 1 |
| Food and beverage | $205 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Solventum Corporation | $151,422 | 3 |
| Pfizer INC. | $115,236 | 5 |
| Insulet Corporation | $101,625 | 74 |
| Intuitive Surgical, INC. | $75,200 | 4 |
| Taiho Oncology, INC. | $49,525 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $47,045 | 22 |
| Catalyst Pharmaceuticals, INC. | $36,772 | 1 |
| Stryker Corporation | $35,295 | 22 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| ASTX727-07 TAIHO ONCOLOGY, INC. | $49,525 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants w… Takeda Pharmaceuticals U.S.A., Inc. | $20,610 |
| TAK-079-3003 A Trial to learn about the Long-term Efficacy and Safety of Mezagitamab Subcutaneous Injection in Adults With Chronic Immune Thrombocyto… Takeda Pharmaceuticals U.S.A., Inc. | $20,610 |
| AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 RANDOMIZED DOUBLEBLIND 3ARM STUDY TO INVESTIGATE IBUZATRELVIR IN ADULTS WITH SYMPTOMATIC COVID19 WHO AR… PFIZER INC. | $15,236 |
| An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (M… Incyte Corporation | $10,201 |
| A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL Takeda Pharmaceuticals U.S.A., Inc. | $5,825 |
| SUMMIT MAX Route 92 Medical, Inc. · NCT05018650 | $2,678 |
| Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Rux… Incyte Corporation | $2,550 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Umass Memorial Medical Center/University Campus
Is Umass Memorial Medical Center/University Campus a good hospital?
Umass Memorial Medical Center/University Campus has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Umass Memorial Medical Center/University Campus?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,116 completed HCAHPS surveys.
How long is the wait in the Umass Memorial Medical Center/University Campus emergency room?
Emergency patients spend a median of 4 h 51 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 8% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Umass Memorial Medical Center/University Campus receive money from drug and device companies?
Drug and device makers reported $651,795 in payments to Umass Memorial Medical Center/University Campus for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.